SYNGENE

Syngene International Limited

Healthcare Research, Analytics & Technology

Share price

₹363

Market cap

₹14,657 Cr

1Y return

▼ 43%

India's first Contract Research Organization, Syngene provides integrated drug discovery, development, and manufacturing services through a single platform known as CRAMS. Established in 1993 as a Biocon subsidiary, the company operates extensive research and manufacturing facilities spanning multiple locations across the country. It serves global pharmaceutical and biotechnology clients with end-to-end solutions, from early-stage research through commercial-scale production.

Investors holding Syngene International Limited

Nippon India Mutual Fund

Mutual Fund

7.73%

DSP Mutual Fund

Mutual Fund

4.61%

Government of Singapore

Foreign Investor

2.13%

SBI Mutual Fund

Mutual Fund

1.95%

Government Pension Fund Global (Norway)

Foreign Investor

1.82%

Institution

1.78%

HSBC Mutual Fund

Mutual Fund

1.55%

Recent moves 10

Mirae Asset Mutual FundDecreased

Mirae Asset Mutual Fund trimmed its Syngene International stake from 1.02% to 0.81%, selling 8,61,450 shares via open market sale.

UTI Mutual FundExited

UTI Mutual Fund, which previously held 1.16 percent of Syngene International Limited, is no longer listed among its disclosed shareholders, indicating either a complete sale or a reduction in stake below the 1 percent reporting threshold.

Government Pension Fund Global (Norway)Exited

Government Pension Fund Global (Norway), which previously held 1.82 percent of Syngene International Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in its stake below the 1 percent reporting threshold.

Nippon India Mutual FundIncreased

Nippon India Mutual Fund increased its stake in Syngene International Limited from 5.99% to 7.73%, acquiring 70,58,607 shares. The value of this transaction was approximately ₹281.39 Cr at a share price of ₹398.55.

Mirae Asset Mutual FundExited

Mirae Asset Mutual Fund, which previously held a 3.27 percent stake in Syngene International Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction of its holding below the 1 percent reporting requirement.

Government of SingaporeDecreased

Government of Singapore decreased its stake in Syngene International Limited from 2.89% to 2.13%, selling 3,026,632 shares. The value of the remaining stake is approximately ₹350 crore.

LICNew position

LIC initiated a new position in Syngene International, acquiring 71,83,419 shares, representing a 1.78% stake in the company. The position is valued at ₹300.99 crore based on the share price of ₹419.45.

HSBC Mutual FundNew position

HSBC Mutual Fund initiated a new position in Syngene International with 62,38,897 shares, representing a 1.55% stake worth ₹260.42 Cr at a share price of ₹417.45.

Nippon India Mutual FundIncreased

Nippon India Mutual Fund bought 16,00,307 shares of Syngene International for ₹69.62 Cr at ₹435.05 apiece in an open market transaction, increasing its stake from 6.72% to 7.12%.

DSP Mutual FundIncreased

DSP Mutual Fund bought 9,93,389 shares of Syngene International for ₹38.83 Cr at ₹390.90 apiece, increasing its stake from 4.79% to 5.03% and crossing the 5% disclosure threshold.

Track the whales in Syngene International Limited

Get alerted the moment a top investor buys or sells.